United States · FDA National Drug Code directory
Senokot
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67618-300_fd1324ab-ef79-42ee-b960-9b032a3a4af2
- Product NDC
- 67618-300
- Form
- TABLET
- Composition / generic term
- standardized senna concentrate
- Labeler
- Atlantis Consumer Healthcare, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 19560601
- Source listing expiry
- 20261231
Source-listed ingredients
- SENNOSIDES — 8.6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (67618-300-10) / 100 TABLET in 1 BOTTLE, PLASTIC · 67618-300-10
- 2 BLISTER PACK in 1 CARTON (67618-300-20) / 10 TABLET in 1 BLISTER PACK · 67618-300-20
- 1 BOTTLE, PLASTIC in 1 CARTON (67618-300-50) / 50 TABLET in 1 BOTTLE, PLASTIC · 67618-300-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →